BMIYX
Price
$7.10
Change
-$0.08 (-1.11%)
Updated
Feb 21 closing price
Net Assets
182.01M
VVIAX
Price
$68.79
Change
-$0.81 (-1.16%)
Updated
Feb 21 closing price
Net Assets
192.55B
Ad is loading...

BMIYX vs VVIAX

Header iconBMIYX vs VVIAX Comparison
Open Charts BMIYX vs VVIAXBanner chart's image
BNY Mellon Income Stock Y
Price$7.10
Change-$0.08 (-1.11%)
VolumeN/A
Net Assets182.01M
Vanguard Value Index Adm
Price$68.79
Change-$0.81 (-1.16%)
VolumeN/A
Net Assets192.55B
BMIYX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMIYX vs. VVIAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMIYX is a StrongBuy and VVIAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 193B vs. BMIYX (182M). VVIAX pays higher dividends than BMIYX: VVIAX (2.36) vs BMIYX (1.92). BMIYX was incepted earlier than VVIAX: BMIYX (9 years) vs VVIAX (24 years). BMIYX is a more actively managed with annual turnover of: 83.54 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than BMIYX: VVIAX (3000) vs BMIYX (1000000). VVIAX annual gain was more profitable for investors over the last year : 14.79 vs. BMIYX (-2.33). VVIAX return over 5 years is better than : 48.95 vs. BMIYX (-11.59).
BMIYXVVIAXBMIYX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD4.7995.39189%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets182M193B0%
Annual Yield % from dividends1.922.3681%
Returns for 1 year-2.3314.79-16%
Returns for 3 years-19.2325.40-76%
Returns for 5 years-11.5948.95-24%
Returns for 10 yearsN/A107.97-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLX157.254.18
+2.73%
Clorox Company
NEOG10.04N/A
N/A
Neogen Corp
NRXS2.31-0.02
-0.85%
Neuraxis
COGT8.00-0.09
-1.11%
Cogent Biosciences
LRMR3.19-0.08
-2.45%
Larimar Therapeutics